AAP
IMCR icon

Arax Advisory Partners’s Immunocore IMCR Stock Holding History

Arax Advisory Partners’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.4K Buy
862
+318
+58% +$9.41K ﹤0.01% 3742
2026
Q1 		$16.4K Sell
544
-842
-61% -$27.2K ﹤0.01% 2203
2025
Q4 		$48.1K Buy
1,386
+1,042
+303% +$36.8K ﹤0.01% 1629
2025
Q3 		$12.5K Buy
344
+42
+14% +$1.43K ﹤0.01% 2496
2025
Q2 		$9.48K Buy
+302
New +$9.38K ﹤0.01% 1989

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Arax Advisory Partners's IMCR Position: Q2 2026 in Review

Arax Advisory Partners increased its Immunocore (IMCR) stake by 58% in Q2 2026, buying an estimated $9.41K and bringing the position to 862 shares worth $27.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3742.

Arax Advisory Partners first reported a position in IMCR in Q2 2025 and has held it in 5 quarters since. The position peaked at $48.1K in Q4 2025. 136 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • Arax Advisory Partners held 862 shares of Immunocore worth $27.4K as of Q2 2026.
  • Arax Advisory Partners bought 318 Immunocore shares in Q2 2026, an estimated $9.41K.
  • Immunocore made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #3742 holding.
  • Arax Advisory Partners first reported a position in Immunocore in Q2 2025 and has held it in 5 quarters since.
  • Arax Advisory Partners's Immunocore position peaked at $48.1K in Q4 2025.
  • 136 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.